respectively). In linear regression analysis, age was the only independent predictor for cAVI (R 2 = 0.239, β = 0.455, P = 0.001). Systolic BP was significantly associated with baPWV (R 2 = 0.225, β = 0.403, P = 0.004). Conclusions In middle-aged normotensive athletes marathon running and ultra-endurance sports had no negative impact on arterial stiffness.
Introduction
the benefits of regular physical activity on atherosclerotic disease and cardiovascular (cV) mortality have been well established in humans (thompson et al. 2003) . there is an ongoing debate on adverse cV health effects of chronic extreme exercise in humans O'Keefe et al. 2012 O'Keefe et al. , 2013 triggered by the growing interest for ultra-endurance events in the middle-aged population Stiefel et al. 2012) . this has resulted in increased participation rates of the age group >40 years in sports events such as Ironman triathlon, marathon and 100 km ultra-marathon lepers and cattagni 2012; Stiefel et al. 2012) . Since a reasonable number of master athletes start exercising vigorously later in life and cV risk factors are already present (De Matos et al. 2011) , it is essential to evaluate their cV risk profile.
there is clear evidence for structural remodeling (increase in arterial lumen size and decrease in wall thickness) of central arteries associated with endurance training (DeVan and Seals 2012; green et al. 2012; Schmidttrucksäss et al. 2000) . Endurance athletes exhibit a more favorable vascular phenotype and higher central arterial compliance compared to their sedentary and/or recreationally active controls (DeVan and Seals 2012; tanaka et al. 1998 Vaitkevicius et al. 1993) . While the impact of endurance training on central arterial compliance is unequivocal among studies (DeVan and Seals 2012; tanaka et al. 1998 Vaitkevicius et al. 1993) , the influence on peripheral arteries is less consistent (Burr et al. 2013; nualnim et al. 2011; tanaka et al. 1998; Vlachopoulos et al. 2010b) .
Arterial stiffness is a widely recognized surrogate marker for atherosclerotic changes of the vascular walls and associated with increased cV events and all-cause mortality (laurent et al. 2006; Vlachopoulos et al. 2010a) . two recent studies, employing the principle of applanation tonometry, revealed higher arterial stiffness in marathon (Vlachopoulos et al. 2010b ) and ultra-marathon runners (Burr et al. 2013) . consequently, the notion has been raised that long-term strenuous exercise may have a deleterious effect on the vascular system. However, it has to be stressed that the applied methods to determine arterial stiffness in the two previous studies are blood pressure (BP) dependent and may therefore introduce potential confounding (Burr et al. 2013; Vlachopoulos et al. 2010b ). In the study by Vlachopoulos et al. (2010b) , compared to control subjects, marathon runners had a significantly higher BP, and the difference in pulse wave velocity (PWV) disappeared after adjustment for BP. recently, a new and BP-independent method was introduced to measure arterial stiffness (Shirai et al. 2006 (Shirai et al. , 2011 . the stiffness parameter called cardio-ankle vascular index (cAVI) has been shown to correlate with cV risk factors (Kubozono et al. 2007 ) and predicts severity of coronary atherosclerosis (nakamura et al. 2008) . therefore, we aimed at assessing the impact of highvolume long-term endurance training on indices of arterial stiffness in marathon runners and ultra-endurance athletes using this BP-independent method. We hypothesized that recreational athletes, marathon runners and ultra-endurance athletes would exhibit no differences in the cAVI (primary endpoint).
Methods

Study design and participants
We recruited nonelite, male marathon runners by an open invitation letter as part of the grand Prix of Bern, a 10-mile race in Switzerland with >25,000 participants. All athletes applied by electronic mail. We excluded subjects with hypertension (resting BP >140/90 mmHg), known hypercholesterinemia and those with a history of cV disease except episodes of palpitations or non sustained arrhythmias. Additionally, current smokers were excluded and pack-years of former smokers were assessed. Study participants were randomly selected and allocated to three pre-defined groups according to their former participations in competitions: group I (recreational athletes, ≤1 marathon), group II (marathon runners, >1 marathon) and group III (ultra-endurance athletes, 78 and 100 km races, long-distance triathlons). Assessment included transthoracic echocardiography, 24-h ambulatory BP monitoring and measurement of arterial stiffness. Before the tests, subjects were asked to abstain from food and caffeine-containing substances (≥3 h) and alcohol (≥24 h), and they were told to refrain from vigorous exercise training for 24 h before the tests. A detailed flowchart about subject recruitment and measurements is represented in Fig. 1 . All athletes provided written informed consent and the protocol was approved by the local ethics committee.
Anthropometry and hemodynamic measurements
Body mass was measured with light clothing to the nearest 0.1 kg using a digital-balanced scale and stature to the nearest 0.5 cm using a wall-mounted stadiometer. Body mass index (BMI) was calculated as body mass divided by stature squared (kg m −2 ). Body surface area was calculated using the DuBois formula (DuBois 1916). resting BP was measured three to five times at the right arm after a 10-min rest in supine position using VaSera VS-1500n (Fukuda Denshi co. ltd, tokyo, Japan). the first measurement was excluded and the mean of all other measurements was used for data analysis.
Sports history
A comprehensive questionnaire was used to ascertain personal and sports histories. lifetime training hours were calculated using the formula: average endurance and strength training hours per week multiplied by 52 multiplied by training year (Wilhelm et al. 2011) . Furthermore, cumulative lifetime competitions were assessed and expressed as marathon equivalents: half marathon × 0.5; marathon × 1.0; mountain marathon × 1.2; 78 km race × 1.8; Ironman triathlon race × 2.5 and 100 km race × 2.5.
Arterial stiffness
Arterial stiffness was measured in supine position using a non-invasive and BP-independent device (Shirai et al. 2011 . Measurements were performed between 15.00 and 18.00 p.m. to minimize the potential impact of diurnal variation in arterial stiffness. Details of this method can be found elsewhere (Shirai et al. 2006) . In brief, subjects rested for at least 10 min in supine position before the first measurement. BP cuffs were placed around each arm and ankle and brachial pulse E-waves were detected at a low cuff pressure of 30-50 mmHg. A phonocardiogram was placed at the right sternal boarder in the second intercostal space. the cAVI is automatically calculated by the system and reflects the stiffness of the aorta, femoral artery and tibial artery. cAVI is determined by the following equation: cAVI = a{(2ρ/ΔP) × ln(P s /P d )PWV 2 } + b, where P s and P d are systolic and diastolic BP, PWV is the pulse wave velocity between heart and ankle, ΔP is P s − P d , ρ is blood density, and a and b are constants. the equation is derived from the Bramwell-Hill's equation (Bramwell 1922) and the stiffness parameter β as defined in Hayashi et al. (1975) . reproducibility of the device has been demonstrated with a mean coefficient of variation of 3.8 % (Shirai et al. 2006) . cAVI was measured at least three times with 3-min time intervals in-between each measurement. the first cAVI measurement was performed to familiarize the subjects with the testing procedure and the result was not included in the analysis. In case of a difference greater than 0.3 in the cAVI between the second and third measurement, another one to two measurements were performed. We took the average of the left and right cAVI and used the mean of all measurements, excluding the first, for data analysis.
24-h Ambulatory blood pressure
Ambulatory BP monitoring was performed over a 24-h period using mobil-0-graph ng ® (IEM, Stolberg, germany), a device that has recently been validated and recommended for clinical use (Wei et al. 2010) . the monitor and the cuff (nondominant upper arm) was attached by a trained physician and a calibration reading was taken to ensure accurate readings. the device was programmed to measure BP every 15 min during the day and every 30 min during the night. BP data were stored in the monitor and then downloaded into device-specific computer software (Hypertension Management Software, client Server, 4.5., IEM, Stolberg, germany). Data were analyzed for the Fig. 1 Flowchart about subject recruitment, selection and measurements entire 24-h period and separately for daytime and nighttime. Subjects were allowed to perform exercise training at moderate intensities for 60 min on the day of the recording. transthoracic echocardiography Standard transthoracic echocardiography was performed (X5-1, 1-5 MHz transducer, iE33, Phillips Healthcare, Zurich, Switzerland) according to recommendations of the European Association of Echocardiography (Evangelista et al. 2008) . Images were stored digitally and analyzed off-line. left ventricular (lV) mass, and end-diastolic and end-systolic volumes were calculated according to current recommendations and indexed for body surface area (lang et al. 2006) . lV ejection fraction was derived from enddiastolic and end-systolic volumes (lang et al. 2006) . Pulse wave Doppler was performed in the apical four-chamber view to obtain peak early filling (E-wave) and late diastolic filling (A-wave) velocities, and peak early filling/late diastolic filling velocity ratio. Pulse wave tissue Doppler imaging was performed in the apical four-chamber view to acquire peak septal mitral annular velocity (e′) (nagueh et al. 2009 ). reproducibility data on cardiac dimensions in an athletic population of our laboratory were published previously (Wilhelm et al. 2012a ).
Statistical analysis
Statistical analyses were performed with SPSS for Windows (Version 17.0, SPSS Inc., chicago, USA). the Kolmogorov-Smirnov test was used to check data for normal distribution. the χ 2 test was performed to compare baseline categorical variables between groups. normally distributed data were presented as mean ± standard deviation (SD), and variables with skewed distribution were shown as median (inter-quartile range, IQr). relations between variables were evaluated by simple regression analysis. Differences in anthropometric characteristics and training volume between the three groups were evaluated using analysis of variance (AnOVA) or Kruskal-Wallis tests, as appropriate. Analysis of covariance (AncOVA) models were applied to detect differences in indices of arterial stiffness, echocardiographic, and 24-h BP data between groups including lifetime training hours as a covariate. We used linear regression models to determine predictors for cAVI and baPWV and adjusted for age, lifetime training hours and cumulative marathon equivalents and in the latter variable also for systolic BP. the level of significance was set at α = 0.05. Because there are no previous studies using cAVI and baPWV in endurance athletes upon which a power calculation could be based on, we included all volunteering subjects of the 105 invited participants of our previous study.
Results
For a related study (in preparation), 208 male athletes applied for participation and were classified according to the predefined groups. From each group, 35 athletes were selected by chance, and a total of 105 athletes were studied. the 105 subjects were re-invited to the present study and 59 volunteered to participate. Eight subjects had to be excluded due to reasons as listed in Fig. 1 , resulting in 51 subjects who were included in the present study. there were no differences in anthropometric characteristics (table 1) and resting BP between the three groups (table 2). Echocardiographic findings revealed no differences in lV mass index, lV end-diastolic volume as well as systolic and diastolic function between groups (table 2). Mean systolic BP during the 24-h recording and during nighttime was highest among ultra-endurance athletes (P = 0.009 and P = 0.018, respectively). the 10-mile race time significantly decreased from group I to III (P = 0.006). Moreover, compared to group I, median lifetime training hours and cumulative marathon equivalents were significantly higher in groups II and III, respectively, (P < 0.001). there was a tendency toward higher training volumes from group I to III in the past 3 months (table 1) .
Arterial stiffness cardio-ankle vascular index and baPWV were not different between groups I and III (see table 3; Fig. 2) . In linear regression analysis, age was the only independent predictor for cAVI (R 2 = 0.239, β = 0.455, P = 0.001). Systolic BP was significantly associated with baPWV (R 2 = 0.225, β = 0.403, P = 0.004, see table 3). Simple linear regression analysis revealed no correlation between resting systolic BP and cAVI (R 2 = 0.035, P = 0.190). Systolic BP significantly correlated with baPWV (R 2 = 0.164, P = 0.004).
Discussion
the main finding of the present study is that in normotensive subjects, a history of many years of very high training volume and large number of strenuous competitions, such as marathons and ultra-endurance races, were not associated with increased indices of arterial stiffness compared to recreational athletes.
In our study, measures of arterial stiffness (cAVI and baPWV) did not differ between ultra-endurance athletes, marathon runners and recreational athletes. this is in contrast to previous work (Burr et al. 2013; Vlachopoulos et al. 2010b ). In the study by Vlachopoulos et al. (2010b) , exercise volume (min day −1 ) was an independent determinant of increased arterial stiffness in marathon runners who trained on average 15 h week −1 for a mean duration of 11 years. In that study, a higher carotid-femoral PWV was found in marathon runners compared to recreational athletes. However, BP was also significantly higher in the marathon group and, after adjustment for BP, the differences in carotid-femoral PWV disappeared. We explicitly studied male, normotensive marathon runners and ultra-endurance athletes. resting BP was well balanced between the groups, and hypertensive subjects (>140/90 mmHg, n = 5) were excluded to avoid bias from the effect of BP on arterial stiffness. nevertheless, ultraendurance athletes had significantly higher mean systolic BP values over the entire 24-h recording and during dayand nighttime (8-9 mmHg), confirming that high-intensity activities may predispose to higher BP (Mark and Janssen 2008) . In another study, Burr et al. (2013) found reduced large artery compliance in 18 ultra-marathon runners compared to physically active age-matched controls. no differences were observed for small artery compliance between the groups and significant relationships between years of ultra-marathon and small artery compliance disappeared after adjustment for age. Importantly, multiple linear regression analysis revealed no associations between training-related variables and either small or large artery compliance. Only in a small subgroup of runners (n = 9), for whom detailed training data were available, reduced arterial compliance was related to longer running distances per training session. the results, however, should be interpreted with caution due to the low sample size studied.
In normotensive middle-aged and older adults, nualnim et al. (2011) observed a lower baPWV in runners and swimmers compared to sedentary control subjects, despite no changes in femoral artery compliance and femoral artery stiffness index. the lower baPWV appears to mirror the positive effects of endurance training on arterial compliance. Importantly, to eliminate potential deleterious effects of chronic physical inactivity on arterial compliance (Schmidt-trucksäss et al. 1999; tanaka et al. 2000) , we chose a healthy and physically active control group that most likely reflects a healthy vascular compliance.
In our study, age was the only significant predictor for cAVI, and resting systolic BP was significantly associated with baPWV. this is in line with previous work showing that both, age and BP are the most powerful and independent predictors of aortic pulse wave velocity (cecelja and chowienczyk 2009). Mountain marathons (n) -1 (3) 2.5 (6) <0.001
Flat marathons (n) 0 (1) 3 (7) 5.5 (9) <0.001
Half marathons (n) 2.5 (9) 10 (16) 10 (12) 0.002 10-mile races (n) 5.5 (8) 10 (11) 15 ( repetitive episodes of arterial shear stress are thought to be the main physiological stimulus evoking vascular adaptations through endothelium-dependent remodeling (tinken et al. 2010 ). In particular, performing vigorous physical activities appears to prevent arterial stiffening in the general population (van de laar et al. 2010) , and according to our data, also in ultra-endurance athletes, which reflect a unique population performing intense and exhaustive exercise over decades. On the other hand, evidence from cross-sectional studies suggests that longterm strenuous exercise may indeed accelerate the atherosclerotic process (Möhlenkamp et al. 2008) . In runners, the number of completed marathons was associated with coronary artery calcification in otherwise healthy subjects (Möhlenkamp et al. 2008) . the underlying mechanisms for structural changes in vessels are multifactorial and not yet fully understood, but inflammatory processes, among others, appear to play a pivotal role. Vigorous exercise such as marathon running leads to an excessive release of circulating pro-inflammatory cytokines (Bernecker et al. 2013; Wilhelm et al. 2012b ), oxidative stress (Knez et al. 2007) and production of vasoactive substances such as endothelin-1 (Otsuki et al. 2007 ) that may contribute to structural remodeling of small arteries, such as the coronary arteries, in the long term. Altogether, the controversial findings from different studies investigating arterial stiffness in athletes (Burr et al. 2013; Knez et al. 2008; nualnim et al. 2011; Vlachopoulos et al. 2010b ) may arise from different methodological approaches, e.g.: (a) different measurement methods to determine arterial stiffness; (b) single gender studies vs. mixed gender studies; (c) inclusion of athletes from different disciplines (runners, swimmers, triathletes) with different training histories and competition experience; (d) most importantly, the selection of different control groups (sedentary vs. active controls).
Some limitations need to be addressed in view of the present findings. Our results are based on a small and heterogeneous group of endurance-trained athletes. Based on the means and standard deviations (power [1 − β] 0.80 and α = 0.05) of our study, a follow-up study verifying our findings would need n = 836 and 15,456 to possess the power to detect a between-group difference in baPWV and Table 2 comparison between measures of arterial stiffness, echocardiography and 24-h ambulatory blood pressure monitoring data between marathon runners, ultra-endurance athletes and recreational athletes Data are expressed as mean ± standard deviation or median (interquartile range). Data were analyzed using AnOVA or Kruskal-Wallis tests, as appropriate. HR heart rate, BP blood pressure, CAVI cardio-ankle vascular index, abPWV brachial-ankle pulse wave velocity, LV left ventricular, E/A ratio peak early filling/late diastolic filling velocity ratio, Peak e′ peak septal mitral annular velocity * Adjusted for lifetime training hours cAVI, respectively. this illustrates the minimal clinical relevance of the between-group differences in indices of arterial stiffness. this is further supported by the finding that an increase in brachial-ankle elasticity index by 1 m s −1 (compared to a 0.14 m s −1 difference between recreational and ultra-endurance athletes) corresponds to a 12 % increase in total cV events (Vlachopoulos et al. 2012) . the calculation of the cAVI assumes blood viscosity to be constant across subjects. It has to be stressed that there is a large variability in blood viscosity among healthy subjects (Parkhurst et al. 2012 ) which could potentially influence arterial stiffness measurements. However, recent work by Parkhurst et al. (2012) revealed that whole blood viscosity does not significantly impact vascular function measures, including carotid-femoral PWV and carotid artery compliance in healthy subjects. nevertheless, to which extent interindividual differences in blood viscosity impact on cAVI is currently unknown and could be a focus of future studies.
Based on the cross-sectional study design, we cannot establish causal relationships between training volume and indices of arterial stiffness. Moreover, arterial stiffness was measured 9 months after the initial assessment. cV risk factors may change over time and may potentially impact on arterial stiffness. to account for this, we reassessed cV risk factors, training history, anthropometric data and resting BP measurements at the second visit when arterial stiffness was assessed. Moreover, exclusion criteria were based on the second examination.
Our data suggest that even long-term participation in ultra-endurance sports has no negative impact on indices of peripheral arterial stiffness. Physiological adaptations of the vasculature to strenuous endurance exercise may result from positive stimuli, such as exercise-induced shear stress improving elastic properties of arteries as well as positive risk factor modification, on the one hand. However, on the other hand, long-term vigorous exercise may also lead to potentially deleterious mechanisms, such as inflammatory processes, vascular oxidative stress and mechanical fatigue of the elastic elements of vessels.
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